19-[(beta-D-glucopyrasyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide structure
|
Common Name | 19-[(beta-D-glucopyrasyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide | ||
---|---|---|---|---|
CAS Number | 919120-78-8 | Molecular Weight | 494.574 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 667.6±55.0 °C at 760 mmHg | |
Molecular Formula | C26H38O9 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 219.6±25.0 °C |
Use of 19-[(beta-D-glucopyrasyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide, the metabolite of Neoandrographolide, inhibits nitric oxide (NO) production in lipopolysaccharide-activated macrophages[1]. |
Name | 1-O-({(1R,4aS,5R)-1,4a-Dimethyl-6-methylene-5-[2-(2-oxo-2,5-dihyd ro-3-furanyl)ethyl]decahydro-1-naphthalenyl}carbonyl)-β-D-glucopy ranose |
---|---|
Synonym | More Synonyms |
Description | 19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide, the metabolite of Neoandrographolide, inhibits nitric oxide (NO) production in lipopolysaccharide-activated macrophages[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 667.6±55.0 °C at 760 mmHg |
Molecular Formula | C26H38O9 |
Molecular Weight | 494.574 |
Flash Point | 219.6±25.0 °C |
Exact Mass | 494.251587 |
PSA | 142.75000 |
LogP | 3.39 |
Vapour Pressure | 0.0±4.6 mmHg at 25°C |
Index of Refraction | 1.583 |
Hazard Codes | Xi |
---|
1-O-({(1R,4aS,5R)-1,4a-Dimethyl-6-methylene-5-[2-(2-oxo-2,5-dihydro-3-furanyl)ethyl]decahydro-1-naphthalenyl}carbonyl)-β-D-glucopyranose |
β-D-Glucopyranose, 1-O-[[(1S,4aR,5S,8aR)-5-[2-(2,5-dihydro-2-oxo-3-furanyl)ethyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenyl]carbonyl]- |
β-D-Glucopyranose, 1-O-[[(1R,4aS,5R)-5-[2-(2,5-dihydro-2-oxo-3-furanyl)ethyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenyl]carbonyl]- |
1-O-({(1S,4aR,5S,8aR)-1,4a-Dimethyl-6-methylene-5-[2-(2-oxo-2,5-dihydro-3-furanyl)ethyl]decahydro-1-naphthalenyl}carbonyl)-β-D-glucopyranose |